The company filed an offer letter for Dietmar Berger, indicating a key addition to the clinical leadership team.
Filing excerpt
10.43*Offer Letter between Registrant and Dietmar Berger, dated November 14, 2024Incorporated herein by reference to an exhibit to our Form 10-Q filed on May 7, 2026
What this signalsFilings often name leadership changes, deals and spending plans.
Vendors
Vendors named
sec-10qchiefMedicalOfficerChangeGet every 10-Q signal for Gilead and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Gilead this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/e3c27b3c-5d43-4871-94ce-f0bcec4b9c2b returns this record as JSON. POST /v1/companies/enrich returns every signal for gilead.com.
{
"signal_id": "e3c27b3c-5d43-4871-94ce-f0bcec4b9c2b",
"signal_type": "sec-10q",
"signal_subtype": "chiefMedicalOfficerChange",
"detected_at": "2026-08-11T08:10:07.74+00:00",
"company": {
"name": "Gilead",
"domain": "gilead.com"
},
"data": {
"detail": "The company filed an offer letter for Dietmar Berger, indicating a key addition to the clinical leadership team. A new Chief Medical Officer often re-evaluates clinical development strategies, technology stacks, and vendor relationships, creating opportunities for clinical trial management, data analytics, and patient recruitment solutions.",
"summary": "Gilead highlights recent appointment of Chief Medical Officer Dietmar Berger.",
"excerpts": "10.43*Offer Letter between Registrant and Dietmar Berger, dated November 14, 2024Incorporated herein by reference to an exhibit to our Form 10-Q filed on May 7, 2026",
"relevance": 0.9,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm",
"filing_date": "2026-08-06",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "06/30",
"sales_relevance": "Clinical/R&D vendor review",
"signal_category": "leadership",
"vendors_mentioned": [
"Wells Fargo, National Association",
"Computershare Trust Company, National Association"
]
}
}
curl https://signals.autobound.ai/v1/signals/e3c27b3c-5d43-4871-94ce-f0bcec4b9c2b \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"gilead.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.